1
|
Denissen J, Havenga B, Reyneke B, Khan S, Khan W. Comparing antibiotic resistance and virulence profiles of Enterococcus faecium, Klebsiella pneumoniae, and Pseudomonas aeruginosa from environmental and clinical settings. Heliyon 2024; 10:e30215. [PMID: 38720709 PMCID: PMC11076977 DOI: 10.1016/j.heliyon.2024.e30215] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/17/2023] [Revised: 04/19/2024] [Accepted: 04/22/2024] [Indexed: 05/12/2024] Open
Abstract
Antibiotic resistance and virulence profiles of Enterococcus faecium, Klebsiella pneumoniae, and Pseudomonas aeruginosa, isolated from water sources collected in informal settlements, were compared to clinical counterparts. Cluster analysis using repetitive extragenic palindromic sequence-based polymerase chain reaction (REP-PCR) indicated that, for each respective species, low genetic relatedness was observed between most of the clinical and environmental isolates, with only one clinical P. aeruginosa (PAO1) and one clinical K. pneumoniae (P2) exhibiting high genetic similarity to the environmental strains. Based on the antibiograms, the clinical E. faecium Ef CD1 was extensively drug resistant (XDR); all K. pneumoniae isolates (n = 12) (except K. pneumoniae ATCC 13883) were multidrug resistant (MDR), while the P. aeruginosa (n = 16) isolates exhibited higher susceptibility profiles. The tetM gene (tetracycline resistance) was identified in 47.4 % (n = 6 environmental; n = 3 clinical) of the E. faecium isolates, while the blaKPC gene (carbapenem resistance) was detected in 52.6 % (n = 7 environmental; n = 3 clinical) and 15.4 % (n = 2 environmental) of the E. faecium and K. pneumoniae isolates, respectively. The E. faecium isolates were predominantly poor biofilm formers, the K. pneumoniae isolates were moderate biofilm formers, while the P. aeruginosa isolates were strong biofilm formers. All E. faecium and K. pneumoniae isolates were gamma (γ)-haemolytic, non-gelatinase producing (E. faecium only), and non-hypermucoviscous (K. pneumoniae only), while the P. aeruginosa isolates exhibited beta (β)-haemolysis and produced gelatinase. The fimH (type 1 fimbriae adhesion) and ugE (uridine diphosphate galacturonate 4-epimerase synthesis) virulence genes were detected in the K. pneumoniae isolates, while the P. aeruginosa isolates possessed the phzM (phenazine production) and algD (alginate biosynthesis) genes. Similarities in antibiotic resistance and virulence profiles of environmental and clinical E. faecium, K. pneumoniae, and P. aeruginosa, thus highlights the potential health risks posed by using environmental water sources for daily water needs in low-and-middle-income countries.
Collapse
Affiliation(s)
- Julia Denissen
- Department of Microbiology, Faculty of Science, Stellenbosch University, Private Bag X1, Stellenbosch, 7602, South Africa
| | - Benjamin Havenga
- Department of Microbiology, Faculty of Science, Stellenbosch University, Private Bag X1, Stellenbosch, 7602, South Africa
| | - Brandon Reyneke
- Faculty of Health Sciences, University of Johannesburg, PO Box 17011, Doornfontein, 2028, South Africa
| | - Sehaam Khan
- Faculty of Health Sciences, University of Johannesburg, PO Box 17011, Doornfontein, 2028, South Africa
| | - Wesaal Khan
- Department of Microbiology, Faculty of Science, Stellenbosch University, Private Bag X1, Stellenbosch, 7602, South Africa
| |
Collapse
|
2
|
Yao R, Ai B, Wang Z, Shen B, Xue G, Yu D. Uncovering Microbial Composition of the Tissue Microenvironment in Bladder Cancer using RNA Sequencing Data. J Cancer 2024; 15:2431-2441. [PMID: 38495492 PMCID: PMC10937280 DOI: 10.7150/jca.93055] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/08/2023] [Accepted: 01/27/2024] [Indexed: 03/19/2024] Open
Abstract
Purpose: Bladder cancer (BC) is one of the top 10 common tumors in the world. It has been reported that microbiota can colonize tissues and play important roles in tumorigenesis and progression. However, the current understanding of microorganisms in the BC tissue microenvironment remains unclear. Methods: In this study, we integrated the RNA-seq data of 479 BC tissue samples from seven datasets combined with a range of bioinformatics tools to explore the landscape of microbiome in the BC tissue microenvironment. Results: The pan-microbiome was estimated to surpass 1,400 genera. A total of seven core microbiota (Bacillus, Corynebacterium, Cutibacterium, Escherichia, Halomonas, Pasteurella, and Streptomyces) were identified. Among them, Bacillus was widely distributed in all datasets with a high relative abundance (10.11% of all samples on average). Moreover, some biological factors, including tissue source and tumor grade, were found significant effects on the microbial composition of the bladder tissue. Pseudomonas, Porphyrobacter, and Acinetobacter were enriched in tumor tissues, while Mycolicibacterium and Streptomyces were enriched in patients who showed durable response to BCG therapy. In addition, we established microbial co-occurrence networks and found that the BCG therapy may attenuate the microbiological interactions. Conclusions: This study clearly provided a microbial landscape of the BC tissue microenvironment, which was important for exploring the interactions between microorganisms and BC tissues. The identified specific taxa might be potential biomarkers for BC.
Collapse
Affiliation(s)
- Ruiqian Yao
- School of Health Science and Engineering, University of Shanghai for Science and Technology, Shanghai 200093, China
- Department of Medical Genetics, Naval Medical University, Xiang-Yin Road, 800, Shanghai 200433, China
| | - Bin Ai
- Department of Precision Medicine, Translational Medicine Research Center, Naval Medical University, Xiang-Yin Road, 800, Shanghai 200433, China
- Shanghai Key Laboratory of Cell Engineering, Shanghai, China
| | - Zeyi Wang
- Department of Urology, Huadong Hospital, Fudan University, Shanghai, China
| | - Bing Shen
- Department of Urology, Shanghai General Hospital Affiliated to Nanjing Medical University, Shanghai, 200080, China
- Department of Urology, Shanghai General Hospital, Shanghai Jiaotong University School of Medicine, Shanghai, 200080, China
| | - Geng Xue
- Department of Medical Genetics, Naval Medical University, Xiang-Yin Road, 800, Shanghai 200433, China
| | - Dong Yu
- Department of Precision Medicine, Translational Medicine Research Center, Naval Medical University, Xiang-Yin Road, 800, Shanghai 200433, China
- Shanghai Key Laboratory of Cell Engineering, Shanghai, China
| |
Collapse
|
3
|
Abou Fayad A, Haraoui LP, Sleiman A, Hussein H, Grenier F, Derbaj G, Itani D, Iweir S, Sherri N, Bazzi W, Rasheed S, Tanelian A, Miari M, el Hafi B, Kanj SS, Kanafani ZA, Daoud Z, Araj GF, Matar GM. Molecular Characteristics of Colistin Resistance in Acinetobacter baumannii and the Activity of Antimicrobial Combination Therapy in a Tertiary Care Medical Center in Lebanon. Microorganisms 2024; 12:349. [PMID: 38399753 PMCID: PMC10892383 DOI: 10.3390/microorganisms12020349] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/22/2023] [Revised: 01/21/2024] [Accepted: 01/26/2024] [Indexed: 02/25/2024] Open
Abstract
(1) Background: Infections with pan-drug-resistant (PDR) bacteria, such as A. baumannii, are becoming increasingly common, especially in healthcare facilities. In this study, we selected 15 colistin-resistant clinical A. baumannii isolates from a hospital in Beirut, Lebanon, to test combination therapies and determine their sequence types (STs) and the mechanism of colistin resistance using whole-genome sequencing (WGS). (2) Methods: Antimicrobial susceptibility testing via broth microdilution against 12 antimicrobials from different classes and growth rate assays were performed. A checkerboard assay was conducted on PDR isolates using six different antimicrobials, each in combination with colistin. Genomic DNA was extracted from all isolates and subjected to WGS. (3) Results: All isolates were resistant to all tested antimicrobials with the one exception that was susceptible to gentamicin. Combining colistin with either meropenem, ceftolozane-tazobactam, or teicoplanin showed synergistic activity. Sequencing data revealed that 67% of the isolates belonged to Pasteur ST2 and 33% to ST187. Furthermore, these isolates harbored a number of resistance genes, including blaOXA-23. Mutations in the pmrC gene were behind colistin resistance. (4) Conclusions: With the rise in antimicrobial resistance and the absence of novel antimicrobial production, alternative treatments must be found. The combination therapy results from this study suggest treatment options for PDR ST2 A. baumannii-infected patients.
Collapse
Affiliation(s)
- Antoine Abou Fayad
- Department of Experimental Pathology, Immunology and Microbiology, Faculty of Medicine, American University of Beirut, Beirut 1107 2020, Lebanon; (A.A.F.); (A.S.); (G.D.); (D.I.); (S.I.); (N.S.); (W.B.); (S.R.); (A.T.); (M.M.)
- Center for Infectious Diseases Research, American University of Beirut, Beirut 1107 2020, Lebanon; (S.S.K.); (Z.A.K.); (G.F.A.)
- World Health Organization (WHO) Collaborating Center for Reference and Research on Bacterial Pathogens, Beirut 1107 2020, Lebanon
| | - Louis-Patrick Haraoui
- Department of Microbiology and Infectious Diseases, Faculty of Medicine and Health Sciences, Université de Sherbrooke, Sherbrooke, QC J1K 2R1, Canada;
- Centre de recherche Charles-Le Moyne, Hôpital Charles-Le Moyne, Greenfield Park, QC J4V 2G9, Canada
| | - Ahmad Sleiman
- Department of Experimental Pathology, Immunology and Microbiology, Faculty of Medicine, American University of Beirut, Beirut 1107 2020, Lebanon; (A.A.F.); (A.S.); (G.D.); (D.I.); (S.I.); (N.S.); (W.B.); (S.R.); (A.T.); (M.M.)
- Center for Infectious Diseases Research, American University of Beirut, Beirut 1107 2020, Lebanon; (S.S.K.); (Z.A.K.); (G.F.A.)
- World Health Organization (WHO) Collaborating Center for Reference and Research on Bacterial Pathogens, Beirut 1107 2020, Lebanon
| | - Hadi Hussein
- Department of Experimental Pathology, Immunology and Microbiology, Faculty of Medicine, American University of Beirut, Beirut 1107 2020, Lebanon; (A.A.F.); (A.S.); (G.D.); (D.I.); (S.I.); (N.S.); (W.B.); (S.R.); (A.T.); (M.M.)
- Center for Infectious Diseases Research, American University of Beirut, Beirut 1107 2020, Lebanon; (S.S.K.); (Z.A.K.); (G.F.A.)
- World Health Organization (WHO) Collaborating Center for Reference and Research on Bacterial Pathogens, Beirut 1107 2020, Lebanon
| | - Frédéric Grenier
- Department of Biology, Faculty of Science, Université de Sherbrooke, Sherbrooke, QC J1K 2R1, Canada;
| | - Ghada Derbaj
- Department of Experimental Pathology, Immunology and Microbiology, Faculty of Medicine, American University of Beirut, Beirut 1107 2020, Lebanon; (A.A.F.); (A.S.); (G.D.); (D.I.); (S.I.); (N.S.); (W.B.); (S.R.); (A.T.); (M.M.)
- Center for Infectious Diseases Research, American University of Beirut, Beirut 1107 2020, Lebanon; (S.S.K.); (Z.A.K.); (G.F.A.)
- World Health Organization (WHO) Collaborating Center for Reference and Research on Bacterial Pathogens, Beirut 1107 2020, Lebanon
| | - Dana Itani
- Department of Experimental Pathology, Immunology and Microbiology, Faculty of Medicine, American University of Beirut, Beirut 1107 2020, Lebanon; (A.A.F.); (A.S.); (G.D.); (D.I.); (S.I.); (N.S.); (W.B.); (S.R.); (A.T.); (M.M.)
- Center for Infectious Diseases Research, American University of Beirut, Beirut 1107 2020, Lebanon; (S.S.K.); (Z.A.K.); (G.F.A.)
- World Health Organization (WHO) Collaborating Center for Reference and Research on Bacterial Pathogens, Beirut 1107 2020, Lebanon
| | - Sereen Iweir
- Department of Experimental Pathology, Immunology and Microbiology, Faculty of Medicine, American University of Beirut, Beirut 1107 2020, Lebanon; (A.A.F.); (A.S.); (G.D.); (D.I.); (S.I.); (N.S.); (W.B.); (S.R.); (A.T.); (M.M.)
- Center for Infectious Diseases Research, American University of Beirut, Beirut 1107 2020, Lebanon; (S.S.K.); (Z.A.K.); (G.F.A.)
- World Health Organization (WHO) Collaborating Center for Reference and Research on Bacterial Pathogens, Beirut 1107 2020, Lebanon
| | - Nour Sherri
- Department of Experimental Pathology, Immunology and Microbiology, Faculty of Medicine, American University of Beirut, Beirut 1107 2020, Lebanon; (A.A.F.); (A.S.); (G.D.); (D.I.); (S.I.); (N.S.); (W.B.); (S.R.); (A.T.); (M.M.)
- Center for Infectious Diseases Research, American University of Beirut, Beirut 1107 2020, Lebanon; (S.S.K.); (Z.A.K.); (G.F.A.)
- World Health Organization (WHO) Collaborating Center for Reference and Research on Bacterial Pathogens, Beirut 1107 2020, Lebanon
| | - Wael Bazzi
- Department of Experimental Pathology, Immunology and Microbiology, Faculty of Medicine, American University of Beirut, Beirut 1107 2020, Lebanon; (A.A.F.); (A.S.); (G.D.); (D.I.); (S.I.); (N.S.); (W.B.); (S.R.); (A.T.); (M.M.)
- Center for Infectious Diseases Research, American University of Beirut, Beirut 1107 2020, Lebanon; (S.S.K.); (Z.A.K.); (G.F.A.)
- World Health Organization (WHO) Collaborating Center for Reference and Research on Bacterial Pathogens, Beirut 1107 2020, Lebanon
| | - Sari Rasheed
- Department of Experimental Pathology, Immunology and Microbiology, Faculty of Medicine, American University of Beirut, Beirut 1107 2020, Lebanon; (A.A.F.); (A.S.); (G.D.); (D.I.); (S.I.); (N.S.); (W.B.); (S.R.); (A.T.); (M.M.)
- Center for Infectious Diseases Research, American University of Beirut, Beirut 1107 2020, Lebanon; (S.S.K.); (Z.A.K.); (G.F.A.)
- World Health Organization (WHO) Collaborating Center for Reference and Research on Bacterial Pathogens, Beirut 1107 2020, Lebanon
| | - Arax Tanelian
- Department of Experimental Pathology, Immunology and Microbiology, Faculty of Medicine, American University of Beirut, Beirut 1107 2020, Lebanon; (A.A.F.); (A.S.); (G.D.); (D.I.); (S.I.); (N.S.); (W.B.); (S.R.); (A.T.); (M.M.)
- Center for Infectious Diseases Research, American University of Beirut, Beirut 1107 2020, Lebanon; (S.S.K.); (Z.A.K.); (G.F.A.)
- World Health Organization (WHO) Collaborating Center for Reference and Research on Bacterial Pathogens, Beirut 1107 2020, Lebanon
| | - Mariam Miari
- Department of Experimental Pathology, Immunology and Microbiology, Faculty of Medicine, American University of Beirut, Beirut 1107 2020, Lebanon; (A.A.F.); (A.S.); (G.D.); (D.I.); (S.I.); (N.S.); (W.B.); (S.R.); (A.T.); (M.M.)
- Center for Infectious Diseases Research, American University of Beirut, Beirut 1107 2020, Lebanon; (S.S.K.); (Z.A.K.); (G.F.A.)
- World Health Organization (WHO) Collaborating Center for Reference and Research on Bacterial Pathogens, Beirut 1107 2020, Lebanon
| | - Bassam el Hafi
- Department of Experimental Pathology, Immunology and Microbiology, Faculty of Medicine, American University of Beirut, Beirut 1107 2020, Lebanon; (A.A.F.); (A.S.); (G.D.); (D.I.); (S.I.); (N.S.); (W.B.); (S.R.); (A.T.); (M.M.)
- Center for Infectious Diseases Research, American University of Beirut, Beirut 1107 2020, Lebanon; (S.S.K.); (Z.A.K.); (G.F.A.)
- World Health Organization (WHO) Collaborating Center for Reference and Research on Bacterial Pathogens, Beirut 1107 2020, Lebanon
| | - Souha S. Kanj
- Center for Infectious Diseases Research, American University of Beirut, Beirut 1107 2020, Lebanon; (S.S.K.); (Z.A.K.); (G.F.A.)
- Division of Infectious Diseases, Department of Internal Medicine, Faculty of Medicine, American University of Beirut, Beirut 1107 2020, Lebanon
| | - Zeina A. Kanafani
- Center for Infectious Diseases Research, American University of Beirut, Beirut 1107 2020, Lebanon; (S.S.K.); (Z.A.K.); (G.F.A.)
- Division of Infectious Diseases, Department of Internal Medicine, Faculty of Medicine, American University of Beirut, Beirut 1107 2020, Lebanon
| | - Ziad Daoud
- Laboratory Department, My Michigan Health Midland Medical Center, College of Medicine, Central Michigan University, Saginaw, MI 48602, USA;
| | - George F. Araj
- Center for Infectious Diseases Research, American University of Beirut, Beirut 1107 2020, Lebanon; (S.S.K.); (Z.A.K.); (G.F.A.)
- Department of Pathology and Laboratory Medicine, Faculty of Medicine, American University of Beirut, Beirut 1107 2020, Lebanon
| | - Ghassan M. Matar
- Department of Experimental Pathology, Immunology and Microbiology, Faculty of Medicine, American University of Beirut, Beirut 1107 2020, Lebanon; (A.A.F.); (A.S.); (G.D.); (D.I.); (S.I.); (N.S.); (W.B.); (S.R.); (A.T.); (M.M.)
- Center for Infectious Diseases Research, American University of Beirut, Beirut 1107 2020, Lebanon; (S.S.K.); (Z.A.K.); (G.F.A.)
- World Health Organization (WHO) Collaborating Center for Reference and Research on Bacterial Pathogens, Beirut 1107 2020, Lebanon
| |
Collapse
|
4
|
Marco-Fuertes A, Marin C, Gimeno-Cardona C, Artal-Muñoz V, Vega S, Montoro-Dasi L. Multidrug-Resistant Commensal and Infection-Causing Staphylococcus spp. Isolated from Companion Animals in the Valencia Region. Vet Sci 2024; 11:54. [PMID: 38393072 PMCID: PMC10891909 DOI: 10.3390/vetsci11020054] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/12/2023] [Revised: 01/10/2024] [Accepted: 01/24/2024] [Indexed: 02/25/2024] Open
Abstract
The emergence of antimicrobial resistance (AMR) and multidrug resistance (MDR) among microorganisms to commonly used antibiotics is a growing concern in both human and veterinary medicine. Companion animals play a significant role in the epidemiology of AMR, as their population is continuously increasing, posing a risk of disseminating AMR, particularly to strains of public health importance, such as methicillin-resistant Staphylococcus strains. Thus, this study aimed to investigate the prevalence of AMR and MDR in commensal and infection-causing Staphylococcus spp. in dogs and cats in Valencia region. For this purpose, 271 samples were taken from veterinary centers to assess antimicrobial susceptibility against 20 antibiotics, including some of the most important antibiotics for the treatment of Staphylococcus infections, including the five last resort antibiotics in this list. Of all the samples, 187 Staphylococcus spp. strains were recovered from asymptomatic and skin-diseased dogs and cats, of which S. pseudintermedius (≈60%) was more prevalent in dogs, while S. felis (≈50%) was more prevalent in cats. In the overall analysis of the isolates, AMR was observed for all antibiotics tested, including those crucial in human medicine. Furthermore, over 70% and 30% of the strains in dogs and cats, respectively, exhibited MDR. This study highlights the significance of monitoring the trends in AMR and MDR among companion animals. The potential contribution of these animals to the dissemination of AMR and its resistance genes to humans, other animals, and their shared environment underscores the necessity for adopting a One Health approach.
Collapse
Affiliation(s)
- Ana Marco-Fuertes
- Departamento de Producción y Sanidad Animal, Salud Pública Veterinaria y Ciencia y Tecnología de los Alimentos, Facultad de Veterinaria, Instituto de Ciencias Biomédicas, Universidad Cardenal Herrera-CEU, CEU Universities, Calle Santiago Ramón y Cajal 20, Alfara del Patriarca, 46115 Valencia, Spain; (A.M.-F.); (C.M.)
| | - Clara Marin
- Departamento de Producción y Sanidad Animal, Salud Pública Veterinaria y Ciencia y Tecnología de los Alimentos, Facultad de Veterinaria, Instituto de Ciencias Biomédicas, Universidad Cardenal Herrera-CEU, CEU Universities, Calle Santiago Ramón y Cajal 20, Alfara del Patriarca, 46115 Valencia, Spain; (A.M.-F.); (C.M.)
| | - Concepción Gimeno-Cardona
- Servicio de Microbiología, Consorcio Hospital General Universitario de Valencia, Facultad de Medicina, Universidad de Valencia, 46014 Valencia, Spain;
| | - Violeta Artal-Muñoz
- Servicio de Microbiología, Consorcio Hospital General Universitario de Valencia, 46014 Valencia, Spain;
| | - Santiago Vega
- Departamento de Producción y Sanidad Animal, Salud Pública Veterinaria y Ciencia y Tecnología de los Alimentos, Facultad de Veterinaria, Instituto de Ciencias Biomédicas, Universidad Cardenal Herrera-CEU, CEU Universities, Calle Santiago Ramón y Cajal 20, Alfara del Patriarca, 46115 Valencia, Spain; (A.M.-F.); (C.M.)
| | - Laura Montoro-Dasi
- Departamento de Producción y Sanidad Animal, Salud Pública Veterinaria y Ciencia y Tecnología de los Alimentos, Facultad de Veterinaria, Instituto de Ciencias Biomédicas, Universidad Cardenal Herrera-CEU, CEU Universities, Calle Santiago Ramón y Cajal 20, Alfara del Patriarca, 46115 Valencia, Spain; (A.M.-F.); (C.M.)
| |
Collapse
|